SERGE GAUTHIER

Select Guide Rating

• Section I: Introduction to the Disease Process 1. Definitions and Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3. Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4. Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias 6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section III: Natural Evolution 11. Natural Decline and Prognostic Factors 12. Global Assessment Measures 13. Depressive Syndrome in Alzheimer’s Disease 14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer’s Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V: Community and Institutional Management 23. Caregiver Support 24. Community-based Formal Support Services Section VI: Ethical and Quality of Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28. Health-related Quality of Life Measurement Techniques in the Manage,ent of Dementia Section VII: Conclusions 29. Future Diagnosis and Management of Alzheimer’s Disease

SERGE GAUTHIER

Select Guide Rating

• Section I: Introduction to the Disease Process 1. Definitions and Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3. Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4. Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias 6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section III: Natural Evolution 11. Natural Decline and Prognostic Factors 12. Global Assessment Measures 13. Depressive Syndrome in Alzheimer’s Disease 14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer’s Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V: Community and Institutional Management 23. Caregiver Support 24. Community-based Formal Support Services Section VI: Ethical and Quality of Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28. Health-related Quality of Life Measurement Techniques in the Manage,ent of Dementia Section VII: Conclusions 29. Future Diagnosis and Management of Alzheimer’s Disease

SERGE GAUTHIER

Select Guide Rating

• Section I: Introduction to the Disease Process 1. Definitions and Diagnostic Criteria 2. Pathophysiology: A Neurochemical Perspective 3. Pathophysiology: An Epidemiological Perspective Section II: Diagnosis 4. Typical Clinical Features 5. Differentiation from Non-Alzheimer Dementias 6. Neuropsychological Assessment 7. Structural Brain Imaging 8. Functional Brain Imaging 9. Electrophysiological Tests 10. Biological Markers Section III: Natural Evolution 11. Natural Decline and Prognostic Factors 12. Global Assessment Measures 13. Depressive Syndrome in Alzheimer’s Disease 14. Cognition 15. Functional Automony 16. Behaviour Section IV: Medical Management 17. Mild Cognitive Impairment and Very Early Stage Alzheimer’s Disease 18. Mild to Moderate Stages 19. Care of Patients in Severe Stage of Dementia 20. Terminal Stage 21. Co-existent Medicial Problems and Concomitant Diseases 22. Management of Neuropsychiatric Symptoms Section V: Community and Institutional Management 23. Caregiver Support 24. Community-based Formal Support Services Section VI: Ethical and Quality of Life: Issues 25. Ethical Issues 26. Competency 27. Genetic Counselling 28. Health-related Quality of Life Measurement Techniques in the Manage,ent of Dementia Section VII: Conclusions 29. Future Diagnosis and Management of Alzheimer’s Disease